Clinical Trial Update: Ext. Long-term Safety Study in CF Patients: Single Arm TIP [Phase 4]

View source ↗

Summary

A Phase 4 long-term safety study of TIP in cystic fibrosis patients has been completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TIP

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Long-term Safety of TIP | Phase 4 | Status: COMPLETED | Results posted: 2015-11-06